Initially Diagnosed:
2013
Current Diagnosis:
Relapsed, Refractory
Treatments Received:
Velcade, Revlimid, dexamethasone, autologous stem cell transplant, Darzalex, Kyprolis, Pomalyst and intrathecal chemotherapy
Andrew’s biggest challenge after receiving his diagnosis was educating himself on this disease. His healthcare team embraced his determination to educate himself, which gave him additional confidence in his doctors. Andrew has kept a positive outlook and is self-motivating. He feels that his multiple myeloma journey has made him a better person in that he is more compassionate and understanding.
Andrew relapsed in December of 2023 with a rare form of myeloma concentrated in the central nervous system. This has forced him to curtail his physical activities but he remains hopeful that the aggressive treatment that he is receiving will allow him to resume his physical activities.
